Loosingcash. You are correct about the PRR update. The piece in the update in fact says to the effect that the potential attaining of both orphan status approval and FDA product approval are the next significant milestones to be met. Both are critical steps to PRRs success. When orphan status is officially granted I would expect it to be a big deal. The fast tracking of FDA approval for Cvac if successful is of course the really big deal. Just my opinions DYOR
fda ods approved, page-24
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $2.355M | 7.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 128197 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |